Los Angeles Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,805
Closed -$30K 2455
2026
Q1
$30K Hold
7,805
﹤0.01% 1625
2025
Q4
$98.6K Buy
+7,805
New +$67K ﹤0.01% 1420
2024
Q3
Sell
-12,652
Closed -$731K 1261
2024
Q2
$731K Buy
+12,652
New +$620K ﹤0.01% 754
2022
Q1
Sell
-628
Closed -$434K 1470
2021
Q4
$434K Hold
628
﹤0.01% 1073
2021
Q3
$465K Sell
628
-153
-20% -$104K ﹤0.01% 1077
2021
Q2
$586K Sell
781
-2,485
-76% -$1.9M ﹤0.01% 1106
2021
Q1
$2.67M Buy
+3,266
New +$2.52M 0.01% 546

Other funds holding OM

Los Angeles Capital Management's OM Position: Q2 2026 in Review

Los Angeles Capital Management sold out of Outset Medical (OM) in Q2 2026, closing a stake of 7,805 shares — an estimated $30K sold.

Los Angeles Capital Management first reported a position in OM in Q1 2021 and held it in 7 quarters. The position peaked at $2.67M in Q1 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Los Angeles Capital Management reported no remaining Outset Medical position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 7,805 Outset Medical shares in Q2 2026, an estimated $30K.
  • Los Angeles Capital Management first reported a position in Outset Medical in Q1 2021 and held it in 7 quarters.
  • Los Angeles Capital Management's Outset Medical position peaked at $2.67M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.